智通财经APP讯，燕之屋(01497)发布公告，于2025年10月22日，该公司斥资72.74万港元回购9万股股 份，每股回购价格为7.85-8.09港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 廈門燕之屋燕窩產業股份有限公司 (於中華人民共和國註冊成立的股份有限公司) 呈交日期： 2025年10月22日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01497 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事 ...

Group 1 - Multiple companies conducted share buybacks on October 21, 2025, with a total of 30 companies listed [1] - The largest buyback was by Cloud Factory (N23027), repurchasing 2.1 million shares for a total of 8.22 million yuan [1][2] - Other notable buybacks include Linklogis Technology (W09959) with 2.38 million shares for 7.45 million yuan and Mengniu Dairy (02319) with 500,000 shares for 7.26 million yuan [2] Group 2 - Cumulative buyback amounts for the year show Cloud Factory (N23027) has repurchased a total of 26.62 million shares, representing 5.786% of its total share capital [2] - Linklogis Technology (W09959) has repurchased 67.82 million shares, accounting for 3.174% of its total share capital [2] - Other companies with significant cumulative buybacks include Stone Four Pharmaceutical (02005) with 39.20 million shares (1.328%) and Kangchen Pharmaceutical (01681) with 6.50 million shares (7.637%) [2][3]

智通财经APP讯，燕之屋(01497)公布，2025年10月21日耗资约80.49万港元回购10万股股份。 ...

燕之屋(01497)公布，2025年10月21日耗资约80.49万港元回购10万股股份。 ...

格隆汇10月21日丨燕之屋(01497.HK)发布公告，2025年10月21日耗资80.5万港元回购10万股，回购价格 每股7.93-8.06港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 廈門燕之屋燕窩產業股份有限公司 (於中華人民共和國註冊成立的股份有限公司) 呈交日期： 2025年10月21日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01497 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事 ...

Investment Rating - The report indicates a positive investment outlook for the bird's nest industry, highlighting its growth potential and market expansion opportunities. Core Insights - The bird's nest industry is transitioning from a luxury product to a more accessible daily health supplement, driven by diverse consumer scenarios and innovative product forms. The market is expected to grow significantly due to structural expansion of consumer demographics and product innovation. Industry Overview - Bird's nest, made from the saliva of the swiftlet, is a high-end health supplement primarily produced in Indonesia and consumed in China, which accounts for over 80% of global consumption. The nutritional benefits include immune enhancement and metabolism promotion [4][5]. - The market size of China's bird's nest industry is projected to grow from 242.22 billion RMB in 2020 to 421.24 billion RMB by 2024, with a compound annual growth rate (CAGR) of 14.6% [36][37]. Industry Characteristics - **Diverse Consumption Scenarios and Product Innovation**: The consumption of bird's nest has expanded beyond traditional gifts and high-end supplements to include daily health, beauty, and maternal care. Product forms are evolving towards convenience, such as ready-to-eat and fresh-cooked options [15][16]. - **Standardized and Intelligent Production**: The industry is moving towards standardized production processes, with stricter regulations enhancing product quality control. Leading companies are adopting automated production lines to improve efficiency [17]. - **Integrated Industry Chain and Channel Fusion**: The industry is experiencing a shift from fragmented operations to integrated supply chains, with a focus on brand building and channel expansion. Online and offline sales channels are increasingly merging [18]. Market Development History - The bird's nest market in China began in the 1990s, facing challenges due to a lack of regulation and quality control. The "blood nest" incident in 2011 led to a comprehensive import ban, prompting the establishment of a traceability system and a new regulatory framework [19][22]. - From 2014 onwards, the market entered a rapid growth phase, with the introduction of ready-to-eat products and the rise of e-commerce platforms, significantly broadening the consumer base [20][23]. Industry Chain Analysis - **Upstream**: The supply of bird's nest is heavily reliant on imports from Malaysia and Indonesia, with a focus on standardization and quality control. As of 2024, 127 overseas bird's nest production enterprises are registered with China's customs [24][27]. - **Midstream**: Companies are shifting from traditional pure bird's nest products to high-value "bird's nest+" products, such as bird's nest porridge and beverages, to drive growth [25][31]. - **Downstream**: The consumer market is characterized by increased traceability awareness and diverse sales channels, with online sales accounting for approximately 45% and offline sales 55% [26][35]. Competitive Landscape - The bird's nest industry is marked by increasing brand concentration and intensified competition. Leading brands like Yan Zhi Wu and Xiao Xian Dun dominate the market, while smaller brands focus on e-commerce and niche marketing [44][45]. - The competitive dynamics are shaped by the scarcity of imported raw materials and the high stability requirements of the supply chain, creating significant barriers to entry for new players [45][46]. Future Outlook - The industry is expected to continue its trend towards high-end concentration and channel diversification, with leading brands enhancing their supply chain control and marketing strategies to maintain competitive advantages [46].

Summary of Key Points Core Viewpoint - A total of 30 companies conducted share buybacks on October 16, 2025, with Xiaomi Group-W leading in terms of buyback amount and quantity [1] Group 1: Buyback Details - Xiaomi Group-W (01810) repurchased 4 million shares for a total of 192 million [1] - Mengniu Dairy (02319) repurchased 1 million shares for 14.44 million [2] - Yun Gongchang (N23027) repurchased 2.01 million shares for 8.19 million [2] Group 2: Cumulative Buyback Data - Xiaomi Group-W has a cumulative buyback of 16.59 million shares, representing 0.060% of total share capital [2] - Mengniu Dairy has a cumulative buyback of 17.32 million shares, representing 0.443% of total share capital [2] - Yun Gongchang has a cumulative buyback of 20.62 million shares, representing 4.483% of total share capital [2] Group 3: Other Notable Buybacks - Lianyi Rong Technology-W (09959) repurchased 2.39 million shares for 7.48 million, with a cumulative total of 60.47 million shares, representing 2.830% of total share capital [2] - Kangning Jiere Pharmaceutical-B (09966) repurchased 400,000 shares for 5.48 million, with a cumulative total of 801,000 shares, representing 0.083% of total share capital [2] - Guisheng Tongqiao-B (02190) repurchased 50,000 shares for 1.24 million, with a cumulative total of 330,350 shares, representing 1.009% of total share capital [2]

格隆汇10月16日丨燕之屋(01497.HK)公告，10月16日耗资153万港元回购19万股，每股回购价8-8.08港 元。 ...